
Cassel Salpeter & Co.’s Q3 healthcare update points to disrupted NIH grant processing, FDA attrition, and tariffs as pressures on drug development and early-stage financing.
Ins and Outs of Comparator Sourcing
Sponsored by IDIS
Mark Ware, Director, Clinical Trial Services at IDIS, explains how procurement teams charged with sourcing comparator drugs for clinical trials can move from a tactical sourcing approach to a strategic approach.
David Regan, Procurement Manager at IDIS, discusses the 10 ways to reduce the risks associated with sourcing comparator drugs.






